바로가기메뉴

본문 바로가기 주메뉴 바로가기

역교잡 방법을 이용한 결핵균 embB 유전자 돌연변이 검출

Detection of embB Gene Mutation of Mycobacterium tuberculosis by Reverse Hybridization Assay

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.58 no.2, pp.129-134
박영길 (대한결핵협회 결핵연구원)
권오정 (성균관대학교)
류성원 (대한결핵협회 결핵연구원)
류우진 (대한결핵협회 결핵연구원)
고원중 (성균관대학교)
조상래 (연세대학교)
배길한 (대한결핵협회 결핵연구원)
유희경 (결핵연구원)
박찬홍 (결핵연구원)
이승헌 (결핵연구원)
심명섭 (결핵연구원)
  • 다운로드 수
  • 조회수

Abstract

Background : Ethambutol (EMB) is one of important first-line drug in the treatment of tuberculosis. Molecular techniques to detect embB gene mutations have been considered as an method to define the EMB resistance. We investigated the mutation rate within embB gene among EMB resistant strains using reverse hybridization techniques. Methods : We made 11 probes that had wild or mutated sequences containing codons 306, 406, or 497 within embB gene respectively. These probes were reverse-hybridized with PCR products amplified from embB gene which were isolated from 149 ethambutol resistant strains and 50 pan-susceptible strains. Results : Out of 149 ethambutol resistant strains, one hundred (67.1%) had mutation at least one base at codon 306, 406, or 497 in embB gene. Mutation at codon 306, 406, 497 were demonstrated in 75 (50.3%), 16 (10.7%), and 13 strains (8.7%) respectively. There were four strains that showed multi-mutation at codon 306 and codon 406 simultaneously. A high proportion (8.1%) had single mutation at codon 406. There was no mutation observed in embB gene among 50 pan-susceptible strains. Conclusion : Reverse hybridization will be useful technique for detection of gene mutation correlated to ethambutol resistance. (Tuberc Respir Dis 2005; 58:129-134)

keywords
Mycobacterium tuberculosis, Genotypes, EmbB, Reverse hybridization, Ethambutol resistance

참고문헌

1.

Kilburn JO. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 1989,

2.

(1995) Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Che�,

3.

(2002) Detection of embB306 mutations in ethambutol- susceptible clinical isolates of Mycobacterium tuber culosis from northwestern Russia implications for genotypic resistance testing,

4.

(2001) Global trends in resistance to antituberculosis drugs,

5.

(1997) The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. ,

6.

(amrevrespirdis1961) The in vitro activity of ethambutol,

7.

(1997) et al. Ethambutol resistance in Mycobacterium tuberculosis critical role of embB mutations. Antimicrob Agents Chemo�,

8.

(1988) Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome,

9.

(1997) Role of embB in natural and acquired resistance to ethambutol in mycobacteria. ,

10.

(jbacteriol1965) Effect of ethambutol on nucleic acid metabolism in Mycobacterium sme gmatis and its reversal by polyamines and divalent cations,

11.

(2000) lysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycoba� cterium tuberculosis.,

12.

(1997) Drug resistant tuber;culosis in Korea,

13.

(1985) Ethambutol induced leakage of phospholipids in Mycobacterium smegmatis,

14.

Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis,

15.

(1995) PCR assay based on DNA coding for 16S rRNA for detection and identification of mycobacteria in clinical samples. J,

16.

(2003) Bai GH. Rapid drug susceptibility testing for isoniazid and rifampicin by reverse hybridization assay.,

17.

(1985) Specific inhibition of spermidine synthesis in Mycobacteria spp by the dextro isomer of ethambutol,

18.

(1996) The embAB genes of Mycobacterium avium encode an Brabinosyl transfe rase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol,

19.

(2004) Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations,

Tuberculosis & Respiratory Diseases